Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,183 | -33,277 | -25,175 | -15,439 | -5,101 |
| Depreciation Amortization | 605 | 2,770 | 2,195 | 1,428 | 845 |
| Accounts receivable | N/A | -2,624 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -4,208 | N/A | N/A | N/A |
| Other Working Capital | 607 | -33,370 | -27,389 | -26,938 | -19,651 |
| Other Operating Activity | 975 | 10,777 | 3,370 | 2,728 | 1,264 |
| Operating Cash Flow | $-10,996 | $-59,932 | $-46,999 | $-38,221 | $-22,643 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48 | -1,041 | -1,052 | -1,018 | -389 |
| Purchase Of Investment | -1,544 | -48,395 | -43,191 | -31,645 | -16,559 |
| Sale Of Investment | 13,495 | 28,200 | 21,900 | 4,850 | N/A |
| Investing Cash Flow | $11,903 | $-21,236 | $-22,343 | $-27,813 | $-16,948 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 7,214 | 7,121 | 6,839 | 6,558 |
| Financing Cash Flow | $N/A | $7,214 | $7,121 | $6,839 | $6,558 |
| Exchange Rate Effect | 200 | -5,175 | -7,120 | -4,312 | -994 |
| Beginning Cash Position | 38,635 | 117,764 | 117,764 | 117,764 | 117,764 |
| End Cash Position | 39,742 | 38,635 | 48,423 | 54,257 | 83,737 |
| Net Cash Flow | $1,107 | $-79,129 | $-69,341 | $-63,507 | $-34,027 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,996 | -59,932 | -46,999 | -38,221 | -22,643 |
| Capital Expenditure | -48 | -1,041 | -1,052 | -1,018 | -389 |
| Free Cash Flow | -11,044 | -60,973 | -48,051 | -39,239 | -23,032 |